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Autoimmune regulator (AIRE) regulates promiscuous expression of tissue-restricted 
antigens in medullary epithelial cells (mTEC) of the thymus. To understand the diverse 
effects of AIRE, it is crucial to elucidate the molecular mechanisms underlying the pro-
cess of AIRE-regulated gene expression. In this study, we generated a recombinant 
AIRE expression variant of the TEC 1A3 human cell line, TEC 1A3 AIREhi, to determine 
genes targeted by AIRE, and using microarray analysis, we identiied 482 genes showing 
signiicant differential expression (P < 0.05; false discovery rate <5%), with 353 upreg-
ulated and 129 downregulated by AIRE expression. Microarray data were validated by 
quantitative PCR, conirming the differential expression of 12 known AIRE-regulated 
genes. Comparison of AIRE-dependent differential expression in our cell line model with 
murine datasets identiied 447 conserved genes with a number of transcription regula-
tory interactions, forming several key nodes, including STAT1, which had over 30 inter-
actions with other AIRE-regulated genes. As STAT1 mutations cause dominant chronic 
mucocutaneous candidiasis and decreased STAT1 levels in monocytes of autoimmune 
polyglandular syndrome 1 (APS-1) patients, it was important to further characterize 
AIRE–STAT1 interactions. TEC 1A3AIREhi were treated with the STAT1 phosphorylation 
inhibitors ludarabine and LLL3 showed that phosphorylated STAT1 (p-STAT1) was not 
responsible for any of the observed differential expression. Moreover, treatment of TEC 
1A3 AIREhi with STAT1 shRNA did not induce any signiicant variation in the expression 
of unphosphorylated STAT1 (U-STAT1) downstream genes, suggesting that these genes 
were directly regulated by AIRE but not via U-STAT1. The novel model system we have 
developed provides potential opportunities for further analysis of the pathogenesis of 
(APS-1) and the wider roles of the AIRE gene.
Keywords: aire gene, sTaT1, auitoimmune polyglandular syndrome 1, tissue-restricted antigens, Tec1 a3 cells
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inTrODUcTiOn
Autoimmune polyglandular syndrome 1 (APS-1) is a rare 
monogenic disorder, with characteristic features of hypoparathy-
roidism, autoimmune Addison’s disease, chronic mucocutaneous 
candidiasis (CMC), and a wide range of other autoimmune 
disorders found at a higher incidence than in the general popu-
lation (1, 2). APS-1 is caused by mutations in the autoimmune 
regulator (AIRE) gene (3, 4), a transcription factor that regulates 
promiscuous expression of tissue-restricted antigens in the thy-
mus and plays a role in central tolerance mechanisms (5). AIRE 
has been found to bind to DNA in a sequence-speciic manner 
(6) and to bind to histone H3. However, the interaction with this 
histone is inhibited by methylation of lysine 4 (K4) or chemical 
modiication of other residues in close proximity to K4. hese 
modiications are typically associated with chromatin that is 
activated for transcription (7–9). AIRE also interacts with several 
other proteins (10) and activates promiscuous gene expression 
of TSA’s by releasing blocked RNA polymerase II (RNA Pol II), 
suggesting its involvement in transcriptional elongation rather 
than transcriptional initiation (11). AIRE/Aire interacts with 
transcriptional co-activator CREB-binding protein (CBP), binds 
to local histone marks H3K4, and recruits positive transcription 
elongation factor b (P-TEFb) by interacting with C-type cyclin 
(CycT1) (7, 12, 13). P-TEFb phosphorylates NELF and DSIF caus-
ing dislodement of the former and converting the latter into an 
elongation factor. his change enables phosphorylated RNA Pol 
II to perform productive elongation and results in the activation 
of gene expression, which proceeds until termination (14). DNA-
dependent protein kinase (DNA-PK) phosphorylates AIRE/Aire 
and inluences its transactivation function (15). Suicient levels of 
RNA Pol II, and unmodiied H3K4, and DNA-PK proteins ensure 
that AIRE/Aire is recruited and lead to the expression of TSA’s 
and their presentation to T-cells by MHC class II determinants. In 
addition, the protein inhibitor of activated STAT1 interacts with 
AIRE to regulate target genes (16). AIRE is a major regulator of 
thousands of TSA genes expressed in mTECs and afects their 
transcription in a stochastic but ordered manner (17). Indeed, 
AIRE is selectively expressed in approximately 50% of MHC class 
IIhi mTECs, and a small subset (1–3%) of the total number of 
mTECs expresses each speciic TSA (10, 18). Among the most 
interesting AIRE-regulated genes are those encoding autoan-
tigens for which TSA’s have been detected in APS-1 patients. 
In fact, serum from APS-1 patients has been found to have high 
titers of autoantibodies against more than 20 tissue-speciic anti-
gens (19). For instance, in APS-1 with hypoparathyroidism, NLR 
family pyrin domain containing 5 (NLRP5) (20) and calcium-
sensing receptor (CaSR) have been identiied as parathyroid 
autoantigens (21). NLRP5 is a cytoplasmic receptor expressed 
most speciically in the chief cells of the parathyroid gland and in 
oocytes (22). Autoantibodies against NLRP5 have been detected 
in almost 50% of APS-1 patients with hypoparathyroidism but 
were absent in all APS-1 patients without hypoparathyroidism 
(20). Autoantibodies against steroid 21-hydroxylase (CYP21A2), 
steroid 17α-hydroxylase (CYP17A1), and cytochrome P450 fam-
ily 11 subfamily A member 1 (CYP11A1) have been detected in 
many APS-1 patients with Addison’s disease years before adrenal 
insuiciency became clinically apparent (23). hese autoantigens 
are also reported to be involved in hypogonadism in APS-1 
patients (20, 24). In addition, autoantibodies against prostate 
antigen transglutaminase 4 (TGM4), a regulator of semen viscos-
ity and promoter of semen coagulation, can be found in male 
patients with APS-1 (25). T1D occurs in only 1–18% of APS-1 
patients but high titer autoantibodies against diabetes-related 
autoantigens, such as glutamic acid decarboxylase isoform 65 
(GAD65), glutamic acid decarboxylase isoform 67 (GAD67), 
aromatic l-amino acid decarboxylase (AADC), and islet antigen 
2 (IA-2) have been detected in 30–66% of APS-1 patients (26, 27). 
APS-1 patients with tryptophan hydroxylase autoantibodies 
develop intestinal malabsorption (28). Interstitial lung disease is 
reported in 6–10% of APS-1 patients in association with autoan-
tibodies to potassium channel-regulating protein (KCNRG) and 
bactericidal/permeability-increasing fold-containing B1 protein 
(BPIFB1) (29, 30). APS-1 patients with hypothyroidism show 
antibodies to thyroglobulin and thyroid peroxidase (31). he 
transcription factors SRY-box 9 (SOX9) and SRY-Box 10 (SOX10) 
were reported to be vitiligo autoantigens in APS-1 patients with 
autoantibodies detected in 15 and 22% of sera, respectively (32). 
Hedstrand et al. (33) reported an autoantigen related to APS-1 
tyrosine hydroxylase, was identiied in sera from patients with 
alopecia areata (AA) with immunoreactivity detected in 44% of 
the 94 APS-1 patients studied and this reactivity associated with 
the presence of AA.
Since the advent of Aire knockout mice, we have been able to 
explore the biological efects of Aire at the systemic, tissue, and 
cellular level and the thymi from these murine models have been 
used to explore the biochemical properties of Aire, particularly 
for determining the downstream targets of aire-regulated gene 
expression (ARGE) (5, 34–39). Cell line models in many respects 
are more suited for exploring the molecular mechanisms of AIRE/
Aire function, as they are not limited by the number of AIRE+/
Aire+ cells in a single tissue, can be easily manipulated by chemical 
and genetic treatments and critically, are the only available option 
for the study of AIRE in a model system of human origin (40). 
Our aim was to determine the human gene targets of ARGE, 
then, to identify and explore any conserved patterns of expression 
between our cell line model and murine ARGE data.
MaTerials anD MeThODs
cell culture
he TEC 1A3 cell line was originally established from fetal and 
postnatal human thymus tissue by Toribio’s group in 1994 (41). 
TEC 1A3 cells (a git from Dr. Gauchon, Inserm U580, Paris) were 
maintained in RPMI 1640 medium with l-glutamine (Lonza) 
supplemented with 10% fetal calf serum (Lonza). Medium for 
cell line variants were supplemented with either zeocin or hygro-
mycin B, dependent on the cell line variant.
generation of Tec 1a3 lp-in host  
cell line
A TEC 1A3 cell line containing a single FRT (Flp recombinase 
target site) was generated using the pFRT/LacZeo vector following 
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the lp-in system manual (012402 version C, Invitrogen). In brief, 
this process involved the transfection of TEC 1A3 cells with a 
pFRT/LacZeo vector using FuGENE6 reagent (Promega). Cells 
were grown in media supplemented with 250  µg/ml zeocin to 
select for those containing the pFRT/LacZeo vector integrated 
into the genome, with cloning rings used to isolate foci to collect 
individual cell lines. Southern blotting was used to screen the dif-
ferent cell lines to identify those containing only a single integrant 
of the pFRT/LacZeo vector. Relative expression eiciency from 
the FRT region for each TEC 1A3/pFRT/LacZeo cell line gener-
ated was estimated by comparing β-galactosidase activity using 
the β-gal assay kit (Invitrogen). he cell line with the highest 
β-galactosidase activity was chosen to be the TEC 1A3 lp-In host 
cell line for subsequent reactions.
generation of stably Transfected 
recombinant aire (raire)  
expression cell lines
Autoimmune regulator cDNA was PCR ampliied from a 
pET31/rAIRE expression vector (a git from Prof. She, Medical 
College of Georgia, USA) using the primers AAAAAAGCTAGC 
CGCCACCATGGCGACGGAC GCGG CGCTA and GCTACA 
GGGCCCTCAATGATGATGATGA TGATG.
he ampliied cDNA was inserted into the multiple-cloning 
site of the pcDNA5/FRT vector using the NheI and ApaI 
restriction sites, generating the pcDNA5/FRT/rAIRE expression 
vector. Both the TEC 1A3 lp-in host cells and T-REx 293 cells 
were seeded into 6-well plates to reach 60–70% conluence ater 
24 h. he cells were co-transfected with 1 µg plasmid DNA (the 
Flp recombinase expression vector pOG44 with the pcDNA5/
FRT/rAIRE expression vector at 20:1 ratio) using 3 µl FuGENE6 
reagent (Promega) per transfection. Ater 24 h, cells were washed 
with PBS then maintained in fresh media supplemented with 
hygromycin B at 150  µg/ml to select for cells containing inte-
grated pcDNA5/FRT/rAIRE expression vector (AIREhi variants).
Western Blotting
Cell pellets were resuspended in 2× loading bufer [100  mM 
tris–Cl (pH 6.8), 4% SDS, 20% glycerol, 0.2% bromophenol blue, 
and 200 mM dithiothreitol] and proteins separated by SDS-PAGE 
[pH8.8, 10% (37:1) acrylamide, 0.375 M tris–Cl, and 0.1% SDS]. 
Ater electrophoresis, gel was transferred to PVDF membrane 
using iblot system (Invitrogen). Primary antibodies used were 
1:1,000 polyclonal goat anti-aire-1 (D-17) IgG (sc-17986, Santa 
Cruz Biotechnology, Inc.) and 1:500 polyclonal goat anti-actin 
(I-19) IgG (sc-1616, Santa Cruz Biotechnology, Inc.). he sec-
ondary antibody used was 1:2,500 polyclonal rabbit anti-goat 
IgG conjugated with peroxidase (A5420, Sigma), visualized 
using EZ-ECL chemiluminescent reagent (Biological Industries). 
he PhosphoPlus Stat1 (Tyr701) antibody kit was used to detect 
STAT1 and p-STAT1 (Tyr701) in samples.
Microarray analysis
RNA was extracted from cell pellets from three separate cultures 
of TEC 1A3 AIRElo cells and three separate cultures of TEC 1A3 
AIREhi cells using the SV Total RNA isolation kit (Promega). he 
quality and quantity of the RNA from all samples was assessed 
(2100 bioanalyzer, RNA 6000 Pico LabChip; Agilent, CA, USA, 
and NanoDrop 1000 spectrophotometer, respectively). Linear 
ampliication of each RNA sample was undertaken following the 
Eberwine procedure (42) using the GeneChip® 3′ IVT Express 
Kit (Afymetrix), and checked again for quality and quantity. 
Fiteen microgram of ampliied cRNA from the three TEC 1A3 
AIRElo cells and three TEC 1A3 AIREhi cells were fragmented and 
each hybridized individually to a separate Human Genome U133 
Plus 2.0 GeneChip (Afymetrix), as speciic in manufacturer’s 
protocols, and subsequently underwent washes. Chips were then 
stained, scanned, and signal intensities for each transcript pro-
duced using GeneChip Operating Sotware. hese data (uploaded 
to GSE 35244) and data generated from wild-type and rAire+ 
HEK 293 cells [GSE24733 (8)] were analyzed using Genespring 
GX v11.0 (Agilent Technologies) with the PLIER16 algorithm 
used to normalize these values, and subsequently analyzed by 
Student’s t-test [P ≤ 0.05 and P ≤ 0.05 with Benjamini–Hochberg 
correction to ensure false discovery rate (FDR) <5%] to deter-
mine genes that showed signiicant diferential expression in the 
AIREhi (rAire+ in HEK) cells compared to AIRElo (Aire−/wild-
type in HEK) cells.
Quantitative and rT-Pcr
RNA was extracted from cells using trizol and puriied from 
the trizol-cell lysate using the Direct-Zol miniprep kit (Zymo 
Research), before being used for cDNA synthesis using the 
Superscipt III First-Strand Synthesis System (Invitrogen) with 
random hexamer primers. cDNA synthesis for all three RNA 
samples from TEC 1A3 AIRElo and TEC 1A3 AIREhi cells used 
for microarray analysis was carried out the same way.
Triplicate QPCR reactions were carried out for each sample 
using Power SYBR® Green PCR (Applied Biosystems) and each 
of the primer pairs listed in Table S1 in Supplementary Material. 
Validation QPCR reactions were carried out in 96 well plates using 
a Stratagene MX3000P QPCR System (Aglient Technologies). 
Other QPCR reactions were carried out in 384-well plates using 
an Applied Bioystems 7900HT Real-Time PCR machine. β-Actin 
expression was tested for each RNA sample on every plate 
and used to normalize Ct values determined for the other genes 
tested. he ΔΔCt method was used to calculate the change in 
relative expression for each gene between AIRElo and AIREhi cells, 
or between untreated and treated AIREhi cells.
RT-PCR was carried out using AmpliTaq Gold 360 (Applied 
Biosystems) under standard reaction conditions using 1  µl 
human adult thymus cDNA (c1234264, AMS biotechnology) 
and primers at a inal concentration of 0.5  µM. he standard 
PCR program from the AmpliTaq Gold 360 product manual was 
used, with an annealing temperature of 60°C and 38 cycles. Gene-
speciic primer sequences are given in Table S3 in Supplementary 
Material.
generation of conserved gene list
Genespring GX v11.0 (Agilent Technologies) was again used 
to analyze data generated on medullary thymic epithelial cells 
from wild-type and Aire knockout mice of the C57BL/6, BALB/c, 
and NOD strains [GSE8564 (38) and GSE12073 (39)], with the 
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PLIER16 algorithm used to normalize raw values. Each dataset 
is the “diferential expression dataset” generated by comparing 
gene expression between normalized data from WT samples and 
normalized data from Aire KO samples. Two “diferential expres-
sion datasets” were generated from NOD mice, together with one 
from each of B6 and Balb/c.
hese datasets, along with our normalized TEC1A3 cell 
line dataset (GSE35244), were then analyzed by Student’s t-test 
(P ≤ 0.05) to determine genes that showed signiicant diferential 
expression in the AIREhi (wild-type mice) cells compared to 
AIRElo (knockout mice) cells. Genespring GX was used to com-
pare individually each analyzed murine dataset with our analyzed 
TEC 1A3 data set to determine gene conservation across two data 
sets. Individual conserved gene lists were exported, compiled, and 
iltered to show only genes with diferential expression reported 
for the human dataset and at least three of the four murine data-
sets, with each reported gene showing a fold-change ≥  1.2 for 
probes from at least three diferent datasets.
Functional analysis of aire-regulated 
genes
he lists of AIRE-regulated genes from both our TEC 1A3 data 
set and from the conserved gene list were analyzed by DAVID1 
(43) and the Edge-Express DB element of Fantom 42 (44).
inhibition and gene Knockdown
he STAT1 phosphorylation inhibitors ludarabine phosphate 
(Sigma) and LLL3, a kind git from Dr. Pui-Kai Li, College of 
Pharmacy, Ohio State University, were dissolved in DMSO and used 
to supplement cell culture media to the inal given concentrations.
Two 21-nucleotide sequences targeting human STAT1 (desig-
nated c48 and c660, based on cDNA position) were subcloned in the 
pLVTHM genome vector (Addgene plasmid 12247) according to 
the manufacturer’s protocol. Briely, siSTAT1-c48 sense oligonu-
cleotide 5′-CGCGTCCCCGCAGGTTCACCAGCTTTATGAT-
TCAAGAGATCATAAAGCTGGTGAACCTGCTTTTTGGA
AAT-3′ and siSTAT1-c48 antisense oligonucleotide 5′-CGATTTC 
C A A A A AG C AG G T T C AC C AG C  T T TA T G A T C T C T T 
GAATCATAAAGCTGGTGAACCTGCGGGGA were annealed, 
and siSTAT1-c660 sense oligonucleotide 5′-CGCGTCCCCGCT 
G A ATG TC AC TG A AC T TAC T TC A A G AG AG TA AG T 
TCAGTGACATTCA GCTTTTTGGAAAT-3′ and siSTAT1-c660 
antisense oligonucleotide 5′-CGATTTCCAAAAAGCTGAATGT
CACTGAACTTACT CTCTTGAAGTAAGTTCAGTGACATTC
AGCGGGGA were also annealed, and each set of annealed oligo-
nucleotides separately cloned into the MluI/ClaI digested vector.
his approach allowed generation of a stem-loop-stem small 
hairpin RNA to efectively reduce PTEN expression levels (45). 
Self-inactivating (SIN) lentiviral vector stocks pseudotyped with 
the vesicular stomatitis virus-G envelope protein (VSV-G) were 
prepared by transient calcium phosphate transfection of the 
human embryonic kidney 293T cell line as previously described. 
Viral titers were estimated using the p24 capsid protein measured 
by enzyme linked immunosorbent assay (46).
1 http://david.abcc.ncifcrf.gov/ (Accessed: March, 2013).
2 http://fantom.gsc.riken.jp/4/edgeexpress/about/ (Accessed: March, 2013).
TEC 1A3 AIREhi cells were transduced with either lentiviral 
vectors carrying the STAT1 knockdown small interfering RNA 
(multiplicity of infection = 100) or the scrambled small inter-
fering RNA (multiplicity of infection = 100). Transduced cells 
were cultured for 7 days, before being harvested for analysis by 
QPCR and western blotting.
resUlTs
site-speciic recombination to generate 
raire expression Variants of Tec  
1a3 cells
Native AIRE expression in the TEC 1A3 cell line was found to be 
too low for reliable measurement when tested using western blot-
ting and quantitative PCR (QPCR) (data not shown). herefore, 
AIRE knockdown was excluded as an appropriate experimental 
option and a rAIRE expression variant of this cell line model was 
generated instead. he lp-in system (Invitrogen) of site-speciic 
recombination was used to integrate a rAIRE expression vector 
into the genome of the TEC 1A3 cell line to minimize experi-
mental variation, which could result from transient transfection 
(Figure 1). A major advantage of this method over those relying 
on random integration is that only a single copy of the expression 
vector is integrated into a single speciic location (the Flp recom-
binase target site—FRT) of the host cell line’s genome. Southern 
blotting and β-galactosidase activity assays were used to identify a 
suitable TEC 1A3 lp-In host cell line variant from several isolated 
individual cells lines generated from the transfection of unmodi-
ied TEC 1A3 cells with the pFRT/LacZeo vector and subsequent 
antibiotic selection using zeocin of those which had the vector 
integrated into their genome (data not shown) (47). his inal 
isogenic TEC 1A3 lp-in host cell line, containing only a single 
copy of the pFRT/LacZeo vector integrated into a transcription-
ally active region of the genome, was used in the second stage 
to generate our cell line model. hese cells were co-transfected 
with the rAIRE expression vector (pcDNA5/FRT-rAIRE) and a 
Flp recombinase expression vector (pOG44). Antibiotic selection 
conditions were again used to select for successful recombinants, 
using hygromycin B instead of zeocin, with initial AIRE expression 
in these cell lines determined by western blotting (Figure 2A) and 
QPCR (Figure 2B). Subsequent analysis of AIRE expression by 
QPCR showed that expression had increased signiicantly in the 
rAIRE expression cell lines compared to the level found in the TEC 
1A3 lp-in host cell line. Sequencing across the FRT integration 
site conirmed that pcDNA5/FRT-rAIRE was integrated into the 
genome at the FRT site (data not shown). Our human thymic cell 
line model system to identify downstream human gene targets of 
AIRE consisted of the TEC 1A3 lp-in host cell line (AIRElo) and 
the rAIRE expression TEC 1A3 cell line (AIREhi).
aire-regulated gene expression  
in human cells
he transcriptional proile of the TEC 1A3 AIRElo and TEC 1A3 
AIREhi cell lines was determined using the Afymetrix Human 
Genome U133 Plus 2.0 array. To compare our data with previously 
FigUre 2 | Autoimmune regulator (AIRE) expression in TEC 1A3. (a) Western blot of protein lysates from TEC 1A3 lp-in host cell line (lane 1) and TEC 1A3 
recombinant AIRE overexpression cell line (lane 2). (B) QPCR determined relative expression levels of AIRE (γCt) after normalization against beta-actin in  
AIRE-low cells (1; green) and AIRE-high cells (10; red). Y-axis was switched to inverse (γCt) so that values go upwards.
FigUre 1 | Basic principle of the Flp-In system of site-speciic recombination to integrate a single copy of the pcDNA5/FRT expression vector containing 
autoimmune regulator cDNA into the genome of the target host cell line (TEC 1A3—FRT).
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published murine data, we applied stringent conditions with 
Benjamini–Hochberg correction, FDR < 5%, and fold-change ≥ 1.2 
to determine gene-diferentially expressed with P ≤ 0.05. here were 
555 probes diferentially expressed (Table S1 in Supplementary 
Material), with 398 probes (including one speciic for AIRE) dis-
playing upregulated levels of expression in the AIREhi compared 
to the AIRElo cell line. here were 21 probes (9 upregulated, 16 
downregulated) that did not have a corresponding gene annotated. 
Diferential expression was iden tiied on several other probes that 
corresponded to the same gene. Overall, this data set indicates dif-
ferential expression for 482 diferent genes, with 353 upregulated 
and 129 downregulated in response to AIRE expression. his 
represents a larger repertoire, with a higher stringency of ARGs 
validation than has been previously reported using a human model 
(Table  1). he list of AIRE-regulated genes determined in our 
model was briely compared with published lists of genes reported 
to be AIRE- or Aire-regulated in other studies, which identiied a 
number of genes found to be similarly regulated in both our study 
and in one or more prior studies (7, 36, 39, 48, 49). Our model was 
validated by QPCR (Table  2), conirming diferential expression 
of the most upregulated gene (CCL5) and downregulated gene 
(MAGEB2), alongside AIRE and a selection of the genes found to 
be expressed in an AIRE/AIRE-dependent manner in this study 
and at least one other study. hymic expression was also conirmed 
TaBle 2 | List of genes identiied to be regulated in an autoimmune regulator (AIRE)-dependent manner in this study and showing at least one other study and 
analyzed in validation by QPCR and RT-PCR.
gene symbol entrez gene i.D. Observed change in  
expression (microarray)
Validation QPcr Thymus rT-Pcr studies determining aire/autoimmune 
regulator (aire)-regulated status
Upregulated genes
AIRE 326 20.66 72214 +
CAMK2Ba 816 1.78 and 2.05 1.83 + (7)
CCL3 414062 3.92 9.32 + (12, 15, 30)
CCL5a 6352 14.98 and 16.70 38.32 + (12, 15, 29)
CEACAM1 634 2.94 5.10 + (15)
IL6 3569 4.02 4.94 + (30)
KRT14 3861 1.52 5.21 + (8)
KRT17 3872 7.88 102 + (7, 15)
LEFTY2 7044 15.63 14395 + (7, 15)
OAS3 4940 1.64 1.54 + (7)
Downregulated genes
DUSP4 1846 −1.59 0.32 + (7)
MAGEB2 4113 −22.33 0.0004 –
TCEA1 6917 −1.48 0.55 + (30)
Change in expression calculated as 2n, where n = difference between mean normalized expression values.
aSigniicant change in expression observed for two probes corresponding to this gene.
TaBle 1 | Comparison of different human cell line models of autoimmune regulator (AIRE)/AIRE-regulated gene expression.
study cell line aire expression expression analysis array no. aire-regulated genes
P ≤ 0.05 P ≤ 0.05 (after correctiona)
Current TEC1A3 (thymus) Site-speciic recombination recombinant  
AIRE (rAIRE) expression
Affymetrix human genome U133 Plus  
2.0 array (over 47,000 transcripts)
5,950 512
U937 (MoDCs) Stable transfection rAIRE expression Atlas array human hematology/immunology  
nylon membranes and custom cDNA chip  
(1,972 separate transcripts)
72 n/a
HEK293 (Kidney) Stable transfection rAIRE expression Illumina Human WG-6_V2_0_R2 BeadChip  
(over 48,000 transcripts)
294 n/a
HEK293 (Kidney) Transient transfection rAIRE expression Affymetrix Human Genome U133 Plus 2.0  
array (over 47,000 transcripts)
1,914 0
aBenjamini–Hochberg correction for multiple testing, with false discovery rate <5%.
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for most of these genes by RT-PCR using commercially available 
human thymic cDNA (Table 2). To determine whether the increase 
of AIRE expression in AIREhi cells regulates the expression of 
genes encoding tissue-speciic autoantigens in APS-1, we analyzed 
microarray data but before applying Benjamini–Hochberg correc-
tion for multiple testing. Six genes encoding APS-1 antigens were 
diferentially expressed with P < 0.05 including CaSR, CYP21A, 
CYP1A2, SOX9, TGM4, and TDRD6 of which CaRS and CYP21A 
(TEC 1A3 cell line dataset: GSE35244) were also diferentially 
expressed in two murine data sets (GSE8564, GSE12073).
aire Preferentially Upregulates genes 
With low levels of expression  
in the absence of aire
he relative fold change in expression for our dataset, when com-
pared against the expression levels in the AIRElo cell line variant 
(Figure  3), shows that the upregulated genes are not normally 
distributed (P <  0.0001) and, ignoring outliers, the expression 
values are positively skewed (skewness = 4.25), whereas the down-
regulated genes were not skewed as heavily (skewness = −1.492). 
he positively skewed distribution of expression values for AIRE 
upregulated genes in the AIRElo cell line suggests that AIRE prefer-
entially upregulates expression for genes that would otherwise be 
expressed at more basal levels (“inactive” genes), rather than those 
whose expression is already elevated (“active” genes). Subsequent 
analysis using the DAVID bioinformatics resource (43) highlighted 
a number of Kyoto encyclopedia of genes and genomes pathways 
containing AIRE/Aire-regulated genes from the conserved list of 
genes, although none of these pathways displayed an abundance 
of AIRE/Aire-regulated genes (4–8 genes per pathway), and none 
had signiicant P-values ater correction for multiple testing 
(P > 0.05 with Benjamini–Hochberg correction), suggesting that 
speciic pathways are not targeted by AIRE/ARGE.
arge in human Thymic cells Maps  
to genes identiied in Previous  
Murine studies
To extend our preliminary comparison, we used Genespring XI 
to analyze the microarray data obtained by Guerau-de-Arellano 
et  al. (38) and Venanzi et  al. (39) from mTECS obtained from 
FigUre 3 | Gene expression proile of TEC 1A3 AIRElo cells vs relative change in expression between AIREhi and AIRElo cells. Gene expression values are averaged 
from three replicates and relative change in expression values calculated for all probes on the Human Genome U133 Plus 2.0 gene array. All dots show probes with 
a signiicant change in expression (P ≤ 0.05 with Benjamini–Hochberg correction), and orange dots show probes with signiicant change in expression ≥ 2.
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wild-type and Aire knockout mice on the B6, Balb/c, and NOD 
genetic backgrounds. hese four diferent murine data sets 
(P ≤  0.05 for each individual data set) were then individually 
compared to the repertoire of probes showing AIRE-dependent 
diferential expression in our TEC 1A3 cell line model (also 
P ≤  0.05). his enabled us to determine which of the identiied 
human probes had at least one murine probe corresponding to 
a homologous gene also showing Aire-dependent diferential 
expression. he four separate comparisons were then compiled, 
revealing over 2,000 human probes with a corresponding murine 
probe in at least one of the murine data-sets (P < 0.0095), but 
more importantly, we identiied a conserved list of 428 diferent 
human genes, which were found to have AIRE-dependent dif-
ferential expression in our TEC 1A3 data-set, had a homologous 
gene in at least three of the murine data sets and fold-change ≥ 1.2 
for probes from at least three of the data-sets(P  <  0.00005, 
FDR < 1%, Table S2 in Supplementary Material). his indicates 
that there are certain gene targets of AIRE/Aire-regulated 
expression that remain constant across diferent species and 
genetic backgrounds. hese gene targets can be used as signposts 
to elucidate the mechanisms used by AIRE/Aire to determine its 
speciicity of interaction.
conserved aire/aire-regulated genes 
and Transcription regulation interaction
We inally used FANTOM4 EdgeExpressDB (44) to identify 
any transcription regulatory interactions that might be present 
within our list of conserved ARGs. his analysis highlighted eight 
nodes present in our list of conserved genes, which had reported 
interactions (edges) to over 200 genes also present in our list of 
conserved ARGs. he nodes for E2F6, IRF7, and STAT1 each had 
over 30 edges with other ARGs, with a number of genes sharing 
edges with at least two nodes (Summary: Figure 4. Full: Figure S2 
in Supplementary Material). It has previously been suggested that 
promiscuous expression in mTECs may operate via conserved 
transcriptional hierarchies (50), which is further supported by 
the EdgeExpressDB analysis of our conserved list of AIRE/Aire 
regulated genes. E2F6 was the node with the largest number of 
edges, the majority of these being ChIP interactions, correspond-
ing to the reported binding of E2F6 (46) to the promoter of the 
gene with which it shares an edge. IRF7 and STAT1 were both 
nodes with a large number of perturbation edges corresponding 
to data obtained from siRNA/miRNA knockdown experiments, 
with IRF7 also having a number of edges corresponding to pre-
dictions of evolutionarily conserved transcription factor-binding 
sites (TFBS). A number of the conserved ARGs returned by the 
EdgeExpress analysis have been studied in investigations explor-
ing autoimmune disorders associated with APS-1. hese include 
OAS1, C4A, and IFIH1 for Type 1 diabetes (51–53) and ID3 and 
C4 for Sjögren’s syndrome (54, 55).
aire regulates Unphosphorylated  
sTaT1 (U-sTaT1)
Results from the EdgeExpress analysis suggest that for the 
identiied gene network, AIRE may act via a hierarchical tran-
scription factor model. We decided to examine this further and 
test a new hypothesis, which AIRE acts directly to regulate the 
expression of each node and indirectly via the nodes to afect 
the diferential expression of the other genes in the network (see 
Figure  4; Figure S2 in Supplementary Material). As patients 
with STAT1 gain-of-function (GOF) mutations also develop 
CMC and autoimmunity (56, 57), we focused on the STAT1 
node, which is involved in the type I IFN system in antiviral 
defense, development of mTECs, and maintenance of thymic 
architecture (58, 59).
STAT1 has been shown to modulate the expression of a large 
number of genes when phosphorylated to its active form, primar-
ily by Janus kinases as part of the JAK–STAT pathway. However, 
FigUre 4 | Summary of EdgeExpress DB output diagram of conserved list of autoimmune regulator (AIRE)/Aire-regulated genes showing key nodes with multiple 
edges and a selection of interacting nodes. Green nodes correspond to nodes reported with many edges, with dark green corresponding to AIRE/Aire upregulated 
genes, and light green to downregulated genes. Yellow and blue nodes correspond to the interacting nodes of AIRE/Aire upregulated and downregulated genes, 
respectively, with each node having three edges or less. Purple edges denote protein–protein interactions, black edges denote transcription factor-binding sites 
edges, green edges denote ChIP interaction edges, and red edges denote siRNA/miRNA perturbation edges.
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STAT1 in its unphosphorylated form (U-STAT1) still has tran-
scriptional regulatory activity, albeit afecting a lower number 
of genes than its phosphorylated form. We, therefore, tested for 
STAT1 phosphorylation in our model and whether inhibition 
of STAT1 phosphorylation or knock down of STAT1 expression 
afected the expression of conserved ARGs that were linked to the 
STAT1 node in the EdgeExpress analysis (STAT1 edges). Most of 
the STAT1 molecules detected in TEC1 A3 were unphosphoryl-
ated. Cells treated with inhibitors of STAT1 phosphorylation, 
ludarabine, or LLL3, showed no diference in STAT1 between 
treated and untreated cells, nor in intracellular STAT1 phospho-
rylation status, as most STAT1 detected was unphosphorylated. 
he absence of phosphorylated STAT1 (p-STAT1) in TEC 1A3 
cells was also observed in HaCat and Jurkat cells as well as in 
normal skin (RTA, unpublished), suggesting that p-STAT1 is not 
present in normal physiological conditions and the phosphoryla-
tion of STAT1 is associated with the reaction to inlammation.
aire simultaneously regulates sTaT1  
and U-sTaT1-regulated genes
We knocked down the expression of STAT1 using two difer-
ent lentivirus delivered anti-STAT1 shRNAs (shRNAc48 and 
shRNAc660) as well as scrambled shRNA as a negative control. 
We used QPCR to determine the change in relative expression 
level of STAT1, and when normalized to β-Actin expression, 
STAT1 shRNAc660 reduced the expression of STAT1 by more than 
fourfold with a lesser reduction in STAT1 expression detected 
when cells were transduced with STAT1 shRNAc48. Western 
blot analysis conirmed this reduction in STAT1 expression with 
both anti-STAT1 shRNAs whereas scrambled STAT1 shRNA 
showed no reduction of STAT1 protein compared to untreated 
cells (data not shown). hus, we used STAT1 shRNAc660 to 
analyze the regulation of STAT1 downstream genes. Knowing 
that U-STAT1 is the main form of STAT1 present in our TEC 
1A3 model, we analyzed the expression of a set of genes previ-
ously shown to be regulated by U-STAT1, including the AIRE-
upregulated IFIT1, IFIT3, IFI44, IRF7, NIPA1, OAS1, and OAS2 
(37, 60) as well as AIRE-regulated but U-STAT1-independent 
genes such as CCL5, CDKN1C, and KRT17. CCL5 and KRT17 
expression are induced by p-STAT1 (38, 61) and, therefore, 
should not be afected by STAT1 knockdown. As expected, there 
was no signiicant change in the expression of AIRE, suggesting 
the addition of the viral vectors and the reduction of STAT1 
does not afect the expression of AIRE. In addition, all the 
tested ARGs, which have been reported as U-STAT1 regulated, 
were unafected by the reduction in the expression of STAT1 
(Figure 5). Similar results were obtained with AIRE-dependent 
genes/U-STAT1 independent. A slight increase was observed 
in the case of IFIT1, but this was not signiicant. hese results 
suggest that U-STAT1 is not involved in the regulation of these 
ARGs and, therefore, the observed increase in their expression 
was more directly mediated by AIRE, and not in an indirect 
FigUre 5 | Change in relative expression levels of STAT1, autoimmune 
regulator (AIRE), and AIRE-dependent genes in TEC 1A3 AIREhi cells treated 
with either anti-STAT1 or scrambled shRNA. The expression of STAT1, AIRE, 
and AIRE-dependent genes were normalized to β-Actin, compared against 
values from the appropriate untreated cells after introducing lentiviral vectors 
that produce either a control “scrambled” shRNA or an anti-STAT1 shRNA. 
Genes tested split into the following groups: AIRE and STAT1 expression are 
indicated in red and orange, respectively. Genes upregulated by AIRE that 
are U-STAT1 independent: CCL5 and CDKN1C (dark purple). Genes 
downregulated by AIRE and previously reported as STAT1 regulated: KRT17 
(gray) (61). Conserved genes upregulated by AIRE that were previously 
reported to be U-STAT regulated: IFIT1, IFI44, IFIT3, OAS2, OAS1, IRF7,  
and NIPA1 (blue) (60). DUSP4 (purple) is a conserved gene downregulated  
by AIRE that has been reported to interact functionally with STAT1 (62).
FigUre 6 | Change in relative expression levels of autoimmune regulator 
(AIRE) downregulated genes, previously reported to be U-STAT1 regulated, 
but not IFN-regulated. TEC 1A3 AIREhi cells were treated with either 
anti-STAT1 or scrambled shRNA, then the expression of 18 genes known  
to be regulated by AIRE and STAT1 were analyzed including 16 genes 
conserved ARGs (green barre) (59) and two genes conserved in ARG in 
TEC1 A3 only (58) (light blue barre). The knockdown of STAT1 revealed 
signiicant variation in relative change in expression (DDCt) of CC chemokine-
binding protein 2 (CCBP2), growth arrest-speciic protein 7 (GAS7), and 
sorting nexin 10 (SNX10), slightly variation (REPS2, VCL, DPYD, TULP2)  
or unchanged (CAV2, PSD3, PRKCA, KSR1, PIP4K2A, FNBP1L, RALGPS1, 
RAP1A, SETT9, DUSP6, and DPY19L1). DDCt values are averaged from 
three replicates.
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manner via upregulated expression of an intermediate tran-
scription factor. Surprisingly, DUSP4, which is a conserved gene 
downregulated by AIRE and reported to interact functionally 
with STAT1 (62), showed an increase in expression by twofold, 
suggesting that for downregulated ARGs, STAT1 may have a 
role in reducing expression of genes that have been reported 
elsewhere as being STAT1 regulated.
are aire-Downregulated genes 
Dependent on U-sTaT1?
To test this hypothesis, we selected 18 genes known to be down-
regulated by AIRE and STAT1. All these were among the conserved 
ARGs except CAV2 and VCL which were found among ARG 
in TEC1 A3 only. he knockdown of STAT1 revealed a mixed 
pattern. here were genes whose expression had been greatly 
afected and, therefore, seem dependent on U-STAT1, such as CC 
chemokine-binding protein 2 (CCBP2), growth arrest-speciic 
protein 7 (GAS7), and sorting nexin 10 (SNX10) with an increase 
of 1.8, 2.0, and 3.8 fold, respectively. In contrast, expression of the 
other genes tested were either unchanged (CAV2, PSD3, PRKCA, 
KSR1, PIP4K2A, FNBP1L, RALGPS1, RAP1A, SETT9, DUSP6, 
and DPY19L1); slightly increased (REPS2); or slightly decreased 
(VCL, DPYD, TULP2). his suggests that the regulation of these 
genes is either completely or relatively independent of U-STAT1 
(Figure 6).
DiscUssiOn
Our cell line model has shown that AIRE up- and downregulates 
the expression of a number of genes in a ratio of approximately 
2:1, as previously observed analysis of ARGE using microarrays 
(5, 36, 38, 39). As also reported in other studies, AIRE appears 
preferentially to upregulate the expression of genes with low lev-
els of expression. his is in keeping with the suggested epigenetic 
mechanism of AIRE-dependent upregulation of expression, 
thus the binding of AIRE to unmethylated H3K4 could play a 
critical role in determining AIRE’s speciicity for its targets. he 
targets of AIRE/Aire-regulated gene expression have an element 
of conservation, as AIRE-dependent diferentially expressed 
genes identiied in this study have been reported in other model 
systems that difer not only in genetic background, but also in 
either species or cell line origin. Genes identiied as being AIRE/
Aire-regulated across several diferent experimental models 
form an ideal list of candidate genes to be studied for elucidating 
the mechanism determining AIRE’s speciicity mechanism for 
its downstream target genes. We were able to identify a larger 
number of AIRE-dependent diferentially expressed genes than 
have been reported in other studies using human cell lines, while 
maintaining a FDR of less than 5%. he development of a cell 
line model facilitates experiments with inhibitors, activators, and 
RNAi, to explore speciic elements of any potential mechanism. 
In addition, the use of the Flp-In system for this model means 
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that it is possible to generate diferent recombinant cell line 
variants that difer by the changes introduced into the integrated 
expression vector, but not difer by the number of expression 
vectors integrated into the cell line genome nor by their integra-
tion/recombination site, thus reducing the scope for experi-
mental variation between the diferent variants. Comparison 
of AIRE-dependent diferential expression in our model with 
murine datasets identiied 447 conserved genes, which represent 
only a portion of AIRE-regulated genes thought to be more than 
two thousands (2, 39), suggesting signiicant variation in the set 
of AIRE/Aire-regulated genes between humans and mice. Our 
model is a good one for studying AIRE as a transcription factor 
and its mechanism of action but less developed for analysis of 
APS-1. For instance, only CaSR, CYP21A, CYP1A2, SOX9, and 
TGM4 out of at least 20 TSA’s were regulated by AIRE in TEC 
1A3 AIREhi. his is not surprising; like in TEC 1A3, most of 
genes encoding APS-1 antigens were not diferentially expressed 
in APS-1 mouse models (5, 34–39). Pontynen et  al.’s indings 
were in keeping with these observations by showing that Aire-
deicient mice had no reactivity against any of 11 out of the 17 
known APS-1 autoantigens (63). his variation also depends on 
mouse background where B6 background is the least autoim-
mune model (63).
Another limitation of our model is the number of AIRE-
regulated genes. More than 2,300 genes have been shown to be 
upregulated over twofold in mTEChi cells (64), but only 353 genes 
were upregulated in our model, which makes it less inclusive than 
the mouse models.
Patients with STAT1 GOF mutations also develop CMC and 
autoimmunity (56, 57). hese patients show increased STAT1 
protein levels as well as an abnormal increase of p-STAT1 on 
stimulation with INF-g (57, 65). In contrast, APS-1 patients 
show decreased total STAT1, as well as lower peak levels of 
p-STAT1 ater INF-γ stimulation (66). herefore, it was of 
particular interest that our data showed that STAT1 is possibly 
regulated by AIRE. In our model, STAT1 was not found to be 
classically phosphorylated and the expression proile of our test 
panel of ARGs linked to STAT1 was not consistently afected 
when these cells were treated with STAT1 phosphorylation 
inhibitors. Similarly, on silencing STAT1 in our cell models, 
we did not observe any consistent change in the expression 
proile of our test panel of ARGs for either cell type or for either 
shRNA used. Based on these indings, we could not conirm 
the hypothesis that AIRE acts via the STAT1 node indirectly to 
afect the diferential expression of the non–node genes down-
stream in the proposed network. his concurs with the results 
of Danso-Abeam et al. (50) who also explored the hierarchical 
transcription factor model of ARGE. hey focused on the 
transcription factor Pdx1 in murine mTECs, whose promis-
cuous expression has been shown to be regulated in an Aire-
dependent manner, and found that Pdx1 deiciency did not 
lead to a reduction inexpression of the expected downstream 
genes. Gucy2d (45) has been proposed as an intermediate 
transcription factor with Aire operating as part of a network. 
While there is strong bioinformatic evidence that Gucy2d is 
a node in a network of ARGs, it has unfortunately not been 
veriied whether it acts as an intermediate transcription factor 
in keeping with the hierarchical transcription factor model 
based on a cascade-like transcriptional control of promiscuous 
gene expression in mTEC (45). It is important to mention here 
that genes not showing altered expression ater adding STAT1 
shRNA may actually be STAT1 dependent. here was no vari-
ation in the expression of these genes because STAT1 knock-
down was incomplete. herefore, these experiments should be 
performed using a diferent set of shRNAs to completely switch 
of STAT1.
Evidence is beginning to accumulate, that when looking 
at global ARGE patterns from pooled cells, AIRE does not 
operate via intermediate transcription factors according to the 
hierarchical transcription factor model to regulate the thou-
sands of genes promiscuously expressed as a result of AIRE 
activity. However, as the range of ARGs has been found to differ 
across individual mTECs (42), it is possible that promiscuously 
expressed transcription factors may modulate the expression 
of their downstream target genes at a local level, but not suf-
ficiently or consistently enough across all cells to produce a 
significant global effect when the transcriptomes of many cells 
are pooled. On the other hand, relatively little is known about 
the mechanism by which AIRE downregulates genes. In the 
case of U-STAT1, a least some genes do not seem to be directly 
regulated by AIRE, for which the hierarchical transcription 
factor model may apply, whereas others seem to be completely 
independent of U-STAT1. For instance, the dual-specific phos-
phatase (DUPS4), which is involved in blocking the activation 
of the extracellular regulated MAP kinase, has previously 
been shown to interact functionally with STAT1 in mediating 
sensitivity to erlotinib in human glioblastoma multiforme cell 
lines (62). This is an excellent example of genes downregulated 
by AIRE via another functionally related molecule. Such a 
relationship is not clear for other genes, including SNX10 with 
expression levels approximately fourfold greater when STAT1 
was knocked down. SNX10 is believed to be a regulator of 
macrophage polarization (67). SNX10 has also been shown to 
have potential role in liver cancer by suppressing microRNA-
30d (68). CCBP2 and GAS7 are two other genes inhibited 
by U-STAT1. CBBP2 is a chemokine decoy receptor and has 
been shown to be associated with metastatic breast cancer 
(69) whereas GAS7 has been shown to regulate neuronal cell 
morphology (70). Little is known about regulation of SNX10, 
CBBP2, and GAS7 expression, and it is unclear what the exact 
functional relationship is between U-STAT1 and these genes. 
Finally, systematic screening of AIRE downregulated genes, 
under each of the nodes shown in Figure S2 in Supplementary 
Material, is necessary to establish the full picture with details 
of genes that are directly regulated by AIRE and those indi-
rectly regulated, i.e., via an intermediate transcription factor 
node in the proposed network. Interestingly, a recent study 
showed that APS-1 patients have 20% decrease of total STAT1 
protein in human monocytes (66). Our findings, showing a 
moderate activation of STAT1 by AIRE in TEC1A3 cells, are 
in keeping with the study by Zimmerman et  al., suggesting 
that STAT1 activation is at least in part AIRE-dependent. 
Such activation could have significant impact on several 
physiological processes including thymic negative selection 
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leading to deletion of autoreactive T-cells and presentation of 
STAT1 antigens by mTEC (5), as well as maintaining STAT1 
expression in monocytes to levels that allow these cells to have 
an adequate response to pathophysiological changes such as 
INF-γ stimulation (66).
Despite the relatively modest number of AIRE-regulated genes 
detected in TEC 1A3 AIREhi compared to APS-1 mouse models, 
the system we have presented here is robust and ofers a new tool 
to dissect the molecular mechanism underlying ARGE.
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FigUre s1 | Gene expression proile of TEC 1A3 AIRElo cells vs relative change 
in expression between AIREhi and AIRElo cells. Gene expression values are 
averaged from three replicates and calculated relative change in expression 
values for all probes on the Human Genome U133 Plus 2.0 gene array. All dots 
show probes with a signiicant change in expression (P ≤ 0.05) with differential 
expression found to be conserved in at least three of the murine microarray 
analyses used in the comparison.
FigUre s2 | Full EdgeExpress DB output igure generated from list of human 
Entrez Gene IDs from conserved list of Autoimmune Regulator/Aire regulated 
genes using default settings. Node and edge colors and styles are as  
determined by EdgeExpress db.
TaBle s1 | List of differentially expressed genes identiied in t-test comparison 
of microarray data (P ≤ 0.05 with Benjamini–Hochberg correction) generated 
from TEC 1A3 AIRElo cells and TEC 1A3 AIREhi cells (GSE35244).
TaBle s2 | List of autoimmune regulator (AIRE)/Aire-regulated genes with  
genes showing conservation in TEC 1A3 data set and at least three murine 
data sets. Data compiled from repertoires of AIRE and Aire-regulated genes 
determined from t-test analysis of microarray data generated from TEC 1A3  
cells (GSE35244), and medullary thymic cells from C57BL/6 mice, BALB/c  
mice and NOD mice for two datasets [GSE12073 (38) and GSE8563 (39)].  
All possible permutations of microarray probes (when more than one for a  
particular conserved gene) are shown.
TaBle s3 | List of gene-speciic primer sequences used for QPCR assays,  
with PrimerBank (49) reference number where appropriate.
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